Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Positive Regulator Molecules

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.

Positive Regulator Molecules

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

M-Cdk Drives Transition Into Mitosis

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Lymphocyte Subtypes in Local Inflammatory Response: A Comparative Analysis of Simple and Complicated Appendicitis.

Medicina (Kaunas, Lithuania)·2025

Same author

Novel HSPB8 mutations in severe early-onset myopathy with involvement of respiratory and cardiac muscles cause proteostasis defects in cell models.

European journal of human genetics : EJHG·2025

Same author

Neuroblastoma Occurring in Nijmegen Breakage Syndrome.

Journal of pediatric hematology/oncology·2024

Same author

Sex-Specific Associations Between Lifestyle Factors and Sick Leave in the Serbian Working Population: Findings from the National Health Survey.

Healthcare (Basel, Switzerland)·2024

Same author

Novel AHR ligand AGT-5 ameliorates type 1 diabetes in mice through regulatory cell activation in the early phase of the disease.

Frontiers in immunology·2024

Same author

Case Report: Extensive Osteomyelitis of the Craniofacial Skeleton Following Operative Fracture Treatment.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India·2024

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

Cyclin D1 immunoreactivity in meningiomas.

Sanja Milenković¹, Tatjana Marinkovic, Milan B Jovanovic

¹Department of Clinical Pathology, Clinical Hospital Centre Zemun, Belgrade, Serbia and Montenegro. kbczemun@afrodita.rcub.bg.ac.yu

Cellular and Molecular Neurobiology

|April 2, 2008

Summary

Cyclin D1 is a useful marker for meningioma proliferation, correlating well with Ki-67 and PCNA. This study confirms its value in assessing tumor grade and potential for growth.

More Related Videos

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

Related Experiment Videos

Last Updated: Jul 6, 2026

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

Area of Science:

Neuro-oncology
Cell cycle regulation
Tumor markers

Background:

Meningiomas are tumors arising from the meninges.
Assessing meningioma proliferation is crucial for predicting behavior.
Cyclin D1's role as a proliferative marker in meningiomas requires further investigation.

Purpose of the Study:

To evaluate Cyclin D1 expression in meningiomas.
To correlate Cyclin D1 with established proliferation markers (Ki-67, PCNA).
To assess the relationship between Cyclin D1 and meningioma World Health Organization (WHO) grade.

Main Methods:

Immunohistochemical analysis of 64 meningioma samples.
Evaluation of Cyclin D1, Ki-67, and PCNA immunoreactivity.
Quantification of positive cells as a percentage of 1000 counted cells.

Main Results:

All meningiomas expressed Cyclin D1, Ki-67, and PCNA.
Cyclin D1 scores strongly correlated with Ki-67 and PCNA (P < 0.01).
Proliferative indexes positively correlated with meningioma WHO grade.

Conclusions:

Cyclin D1 is a valuable marker for assessing meningioma proliferation.
Cyclin D1 aids in correlating tumor grade with proliferative activity.
Further research can utilize Cyclin D1 for meningioma prognostication.